Vancouver, British Columbia–(Newsfile Corp. – December 11, 2023) – ME Therapeutics Holdings Inc. (CSE: METX), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, is pleased to announce that the Company’s common shares are now listed on the Frankfurt Stock Exchange (FSE) under the symbol Q9T.
“Listing on the Frankfurt Stock Exchange is an important step for the Company as it provides us with an opportunity to expand our investor base to Europe and provide greater liquidity while we continue to develop our novel myeloid cell focussed immuno-oncology drug candidates.” – Salim Dhanji, PhD, CEO.
The Frankfurt Stock Exchange is one of the world’s largest trading centres for securities and is the largest exchange in Germany. The FSE facilitates advanced electronic trading, settlement and information systems and enables cross-border trading for international investors.
The Company…
